Norway· NO-ID_2A04274D-6CBE-4CB1-8816-BF760F8A97D5
Tyruko
A natalizumab product containing natalizumab, registered in Norway by Sandoz GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Natalizumab is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AG03 (natalizumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Natalizumab · ATC L04AG03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Natalizumab
- Manufacturer
- Sandoz GmbH
- Country
- Norway (NO)
- ATC code
- L04AG03
- ATC class
- Natalizumab
- Defined daily dose
- 10 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_2A04274D-6CBE-4CB1-8816-BF760F8A97D5
- no_varenummer54566215NOK 15973.2
- gtin7613421134426
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
323 interactions on record for natalizumab.
Graded by severity as the source publishes them — 301 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Natalizumab · interactions on record
323 records
- 301 severe
- 15 moderate
- 7 minor
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Natalizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTyrukoSandoz GmbH
- CzechiaTYRUKOSandoz GmbH, Kundl
- BelgiumTyruko 300 mgSandoz
- IcelandTyrukoSandoz GmbH*
- PolandTyrukoSandoz GmbH
- SwedenTyruko 300 mg Koncentrat till infusionsvätska, lösningSandoz GmbH
- IrelandTyruko 300 mg concentrate for solution for infusionPolpharma Biologics S.A.
- SpainTYRUKO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONSandoz Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Tyruko, Tysabri
- Liechtenstein · Tyruko, Tysabri
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75149be7-4cd5-44e2-99d8-3574506518f7 GET /v1/drugs/75149be7-4cd5-44e2-99d8-3574506518f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Natalizumab",
"merkevare_id": "ID_2A04274D-6CBE-4CB1-8816-BF760F8A97D5",
"name_form_strength": "Tyruko kons til inf oppl 300 mg",
"prescription_group": "C"
}See everything about natalizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.